UK Animal Vaccine Market to Reach $1,318.4 million in 2035, Growing at 6.4% CAGR

UK Animal vaccine market valued at $712.0 million in 2025 and is projected to reach $1,318.4 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). The market covers preventive vaccines developed for livestock and companion animals to manage infectious diseases, improve animal health, and enhance productivity. Key product categories include porcine vaccines, poultry vaccines, livestock vaccines (cattle, sheep, and goats), aquaculture vaccines, companion animal vaccines, and other specialty animal vaccines. Market growth is supported by the UK’s strong livestock industry, extensive poultry production, and growing companion animal population. The country houses over 9 million cattle, 4 million sheep, and 3.5 million pigs, while the poultry sector produces more than 1.2 billion birds annually. Additionally, the companion animal population exceeds 20 million pets, creating sustained demand for preventive and therapeutic vaccines.

Browse the full report description of “UK Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/uk-animal-vaccine-market

Government regulations, disease surveillance programs, and biosecurity measures are major growth drivers. The UK Department for Environment, Food & Rural Affairs (DEFRA) and the Veterinary Medicines Directorate (VMD) oversee animal health standards, vaccine approvals, and national immunization programs. Preventive vaccination against transboundary diseases like avian influenza, foot-and-mouth disease, and porcine reproductive and respiratory syndrome remains a priority, ensuring consistent market demand.

Key Statistics: UK Animal Vaccines at a Glance

• The UK livestock population includes over 9 million cattle, 4 million sheep, and 3.5 million pigs, forming a significant addressable market for veterinary vaccines.
• Poultry production exceeds 1.2 billion birds annually, reinforcing ongoing vaccine utilization for avian disease prevention.
• Companion animals exceed 20 million in number, sustaining demand for routine and advanced vaccination.

Key Innovators Driving UK Animal Vaccine Transformation

The key players in the UK animal vaccine market include Benchmark Holdings plc, Elanco Animal Health UK, Merck Sharp & Dohme Limited, Phibro Animal Health Corporation, Zoetis UK Limited, among others.

• In July 2025, Zoetis expanded its vaccine manufacturing capacity in the United Kingdom to support livestock and companion animal vaccine supply and improve distribution efficiency across Europe.
• In May 2025, MSD Animal Health introduced an updated recombinant vaccine portfolio in the UK, targeting disease prevention in cattle and poultry and supporting efforts to reduce antibiotic use in commercial farming.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Technology
• Competitive Landscape - Benchmark Holdings plc, Elanco Animal Health UK, Merck Sharp & Dohme Limited, Phibro Animal Health Corporation, Zoetis UK Limited, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

UK Animal Vaccine Market Report Segment

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Other

By Technology

• Live Attenuated Vaccine
• Killed/Inactive Vaccine
• Recombinant Vaccine
• Vectored Vaccine
• Subunit Vaccine
• DNA Vaccine
• Chimeric Vaccine
• Others

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/uk-animal-vaccine-market